InsidersTradesSigma
Follow the STEMLINE THERAPEUTICS INC stock price and the full insider trade history of the company, a listed equity based in United States. Shares are quoted on the US market, under the authority of SEC (Form 4). The latest transaction was reported on 21 January 2016 (Cession). Among the most active insiders: Gionco David. All data is accessible without an account.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
3 of 3 declarations
STEMLINE THERAPEUTICS INC is a biopharmaceutical company focused on developing treatments for cancer and hematological diseases. It is listed on the NASDAQ.